1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung CancerHemic and Lymphatic Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, hematologic disorder, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasmNot yet recruitingPhase 22025-12-26NCT07303881